BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 32442887)

  • 1. The Cambridge Neuropsychological Test Automated Battery (CANTAB) Versus the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) for the Assessment of Cognitive Function in Patients with Multiple Sclerosis.
    Talebi M; Majdi A; Kamari F; Sadigh-Eteghad S
    Mult Scler Relat Disord; 2020 Aug; 43():102172. PubMed ID: 32442887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The correlation between circulating inflammatory, oxidative stress, and neurotrophic factors level with the cognitive outcomes in multiple sclerosis patients.
    Talebi M; Majdi A; Nasiri E; Naseri A; Sadigh-Eteghad S
    Neurol Sci; 2021 Jun; 42(6):2291-2300. PubMed ID: 33033896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a Brief Computerized Cognitive Assessment in Multiple Sclerosis (BCCAMS) and comparison with reference batteries.
    Maubeuge N; Deloire MS; Brochet B; Charré-Morin J; Saubusse A; Ruet A
    Mult Scler; 2022 Jun; 28(7):1112-1120. PubMed ID: 34766866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The subtleties of cognitive decline in multiple sclerosis: an exploratory study using hierarchichal cluster analysis of CANTAB results.
    Cabeça HLS; Rocha LC; Sabbá AF; Tomás AM; Bento-Torres NVO; Anthony DC; Diniz CWP
    BMC Neurol; 2018 Sep; 18(1):140. PubMed ID: 30200902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity and sensitivity of Canadian normative data for the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) battery.
    Berard JA; Walker LAS
    Mult Scler Relat Disord; 2022 Jul; 63():103865. PubMed ID: 35580469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing Web-Based and Lab-Based Cognitive Assessment Using the Cambridge Neuropsychological Test Automated Battery: A Within-Subjects Counterbalanced Study.
    Backx R; Skirrow C; Dente P; Barnett JH; Cormack FK
    J Med Internet Res; 2020 Aug; 22(8):e16792. PubMed ID: 32749999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the French version of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).
    Maubeuge N; Deloire MSA; Brochet B; Ehrlé N; Charré-Morin J; Saubusse A; Ruet A;
    Mult Scler Relat Disord; 2021 Feb; 48():102692. PubMed ID: 33352358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross cultural validation of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) and the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).
    Dusankova JB; Kalincik T; Havrdova E; Benedict RH
    Clin Neuropsychol; 2012; 26(7):1186-200. PubMed ID: 23034066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinctive Pattern of Cognitive Disorders During Multiple Sclerosis Relapse and Recovery Based on Computerized CANTAB Tests.
    Giedraitiene N; Kaubrys G
    Front Neurol; 2019; 10():572. PubMed ID: 31214108
    [No Abstract]   [Full Text] [Related]  

  • 10. Sensitivity of conventional cognitive tests in multiple sclerosis: Application of item response theory.
    Raimo S; Giorgini R; Gaita M; Costanzo A; Spitaleri D; Palermo L; Liuzza MT; Santangelo G
    Mult Scler Relat Disord; 2023 Jan; 69():104440. PubMed ID: 36495845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) in the Italian population.
    Migliore S; Ghazaryan A; Simonelli I; Pasqualetti P; Landi D; Palmieri MG; Moffa F; Rinaldi P; Vernieri F; Filippi MM
    Neurol Sci; 2016 Aug; 37(8):1261-70. PubMed ID: 27095052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting Subtle Cognitive Impairment in Multiple Sclerosis with the Montreal Cognitive Assessment.
    Charest K; Tremblay A; Langlois R; Roger É; Duquette P; Rouleau I
    Can J Neurol Sci; 2020 Sep; 47(5):620-626. PubMed ID: 32450922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS.
    Strober L; Englert J; Munschauer F; Weinstock-Guttman B; Rao S; Benedict RH
    Mult Scler; 2009 Sep; 15(9):1077-84. PubMed ID: 19556311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The minimal neuropsychological assessment of MS patients (MACFIMS): normative data of the Italian population.
    Grossi P; Portaccio E; Bellomi F; Bianchi V; Cilia S; Falautano M; Goretti B; Pietrolongo E; Viterbo RG; Messmer Uccelli M
    Neurol Sci; 2020 Jun; 41(6):1489-1496. PubMed ID: 31953702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the abbreviated minimal assessment of cognitive function in multiple sclerosis (aMACFIMS) and the brief international cognitive assessment for multiple sclerosis (BICAMS).
    Gromisch ES; Portnoy JG; Foley FW
    J Neurol Sci; 2018 May; 388():70-75. PubMed ID: 29627034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of regression-based norms in interpreting the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).
    Parmenter BA; Testa SM; Schretlen DJ; Weinstock-Guttman B; Benedict RH
    J Int Neuropsychol Soc; 2010 Jan; 16(1):6-16. PubMed ID: 19796441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity and reliability of a Persian translation of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS).
    Eshaghi A; Riyahi-Alam S; Roostaei T; Haeri G; Aghsaei A; Aidi MR; Pouretemad HR; Zarei M; Farhang S; Saeedi R; Nazeri A; Ganjgahi H; Etesam F; Azimi AR; Benedict RH; Sahraian MA
    Clin Neuropsychol; 2012; 26(6):975-84. PubMed ID: 22681459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trail Making Test Could Predict Impairment in Cognitive Domains in Patients with Multiple Sclerosis: A Study of Diagnostic Accuracy.
    Kabiri S; Jameie M; Balali P; Adib Moradi S; Sanjari Moghaddam H; Aghamollaii V; Harirchian MH
    Arch Clin Neuropsychol; 2023 Jan; 38(1):37-48. PubMed ID: 35901460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the Neuronorma battery for neuropsychological assessment in multiple sclerosis.
    Matías-Guiu JA; Sánchez-Benavides G; Rivera-Àvila N; Cortés-Martínez A; Delgado-Alonso C; Delgado-Álvarez A; Montero P; Pytel V; Matías-Guiu J; Peña-Casanova J
    Mult Scler Relat Disord; 2020 Jul; 42():102070. PubMed ID: 32330845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Italian validation of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) and the application of the Cognitive Impairment Index scoring procedure in MS patients.
    Argento O; Incerti CC; Quartuccio ME; Magistrale G; Francia A; Caltagirone C; Pisani V; Nocentini U
    Neurol Sci; 2018 Jul; 39(7):1237-1244. PubMed ID: 29704074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.